FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037602988> ?p ?o ?g. }

• W2037602988 endingPage "2280" @default.
• W2037602988 startingPage "2274" @default.
• W2037602988 abstract "ABSTRACT Tigecycline was initially approved by the U.S. Food and Drug Administration (FDA) in June 2005. We assessed the evolution of tigecycline in vitro activities since the initial approval of tigecycline for clinical use by analyzing the results of 7 years (2006 to 2012) of data from the SENTRY Antimicrobial Surveillance Program in the United States. We also analyzed trends over time for key resistance phenotypes. The analyses included 68,608 unique clinical isolates collected from 29 medical centers and tested for susceptibility using reference broth microdilution methods. Tigecycline was highly active against Gram-positive organisms, with MIC 50 and MIC 90 values of 0.12 and 0.25 μg/ml for Staphylococcus aureus (28,278 strains; >99.9% susceptible), 0.06 to 0.12 and 0.12 to 0.25 μg/ml for enterococci (99.3 to 99.6% susceptible), and ≤0.03 and ≤0.03 to 0.06 μg/ml for streptococci (99.9 to 100.0% susceptible), respectively. When tested against 20,457 Enterobacteriaceae strains, tigecycline MIC 50 and MIC 90 values were 0.25 and 1 μg/ml, respectively (98.3% susceptible using U.S. FDA breakpoints). No trend toward increasing tigecycline resistance (nonsusceptibility) was observed for any species or group during the study period. The prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae increased from 4.4 and 0.5%, in 2006 to 8.5 and 1.5% in 2012, respectively. During the same period, the prevalence of Escherichia coli and Klebsiella spp. with an extended-spectrum β-lactamase (ESBL) phenotype increased from 5.8 and 9.1% to 11.1 and 20.4%, respectively, whereas rates of meropenem-nonsusceptible Klebsiella pneumoniae escalated from 2.2% in 2006 to 10.8% in 2012. The results of this investigation show that tigecycline generally retained potent activities against clinically important organisms isolated in U.S. institutions, including MDR organism subsets of Gram-positive and Gram-negative pathogens." @default.
• W2037602988 created "2016-06-24" @default.
• W2037602988 creator A5006715126 @default.
• W2037602988 creator A5008542312 @default.
• W2037602988 creator A5026620873 @default.
• W2037602988 creator A5037843249 @default.
• W2037602988 date "2014-04-01" @default.
• W2037602988 modified "2023-10-02" @default.
• W2037602988 title "Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012)" @default.
• W2037602988 cites W1971392136 @default.
• W2037602988 cites W1975005758 @default.
• W2037602988 cites W1975787644 @default.
• W2037602988 cites W1985109169 @default.
• W2037602988 cites W2009364528 @default.
• W2037602988 cites W2020709619 @default.
• W2037602988 cites W2031250450 @default.
• W2037602988 cites W2046583637 @default.
• W2037602988 cites W2087081816 @default.
• W2037602988 cites W2100649441 @default.
• W2037602988 cites W2108742677 @default.
• W2037602988 cites W2125474917 @default.
• W2037602988 cites W2125893214 @default.
• W2037602988 cites W2129071962 @default.
• W2037602988 cites W2140855680 @default.
• W2037602988 cites W2142343447 @default.
• W2037602988 cites W2145111808 @default.
• W2037602988 cites W2148052544 @default.
• W2037602988 cites W2148134051 @default.
• W2037602988 cites W2151150074 @default.
• W2037602988 cites W2154233284 @default.
• W2037602988 cites W2155301516 @default.
• W2037602988 cites W2417472143 @default.
• W2037602988 doi "https://doi.org/10.1128/aac.02684-13" @default.
• W2037602988 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4023762" @default.
• W2037602988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24492361" @default.
• W2037602988 hasPublicationYear "2014" @default.
• W2037602988 type Work @default.
• W2037602988 sameAs 2037602988 @default.
• W2037602988 citedByCount "42" @default.
• W2037602988 countsByYear W20376029882014 @default.
• W2037602988 countsByYear W20376029882015 @default.
• W2037602988 countsByYear W20376029882016 @default.
• W2037602988 countsByYear W20376029882017 @default.
• W2037602988 countsByYear W20376029882018 @default.
• W2037602988 countsByYear W20376029882019 @default.
• W2037602988 countsByYear W20376029882020 @default.
• W2037602988 countsByYear W20376029882021 @default.
• W2037602988 countsByYear W20376029882022 @default.
• W2037602988 countsByYear W20376029882023 @default.
• W2037602988 crossrefType "journal-article" @default.
• W2037602988 hasAuthorship W2037602988A5006715126 @default.
• W2037602988 hasAuthorship W2037602988A5008542312 @default.
• W2037602988 hasAuthorship W2037602988A5026620873 @default.
• W2037602988 hasAuthorship W2037602988A5037843249 @default.
• W2037602988 hasBestOaLocation W20376029881 @default.
• W2037602988 hasConcept C104317684 @default.
• W2037602988 hasConcept C114851261 @default.
• W2037602988 hasConcept C176947019 @default.
• W2037602988 hasConcept C2777027569 @default.
• W2037602988 hasConcept C2778910516 @default.
• W2037602988 hasConcept C2780950330 @default.
• W2037602988 hasConcept C42972112 @default.
• W2037602988 hasConcept C4937899 @default.
• W2037602988 hasConcept C501593827 @default.
• W2037602988 hasConcept C547475151 @default.
• W2037602988 hasConcept C55493867 @default.
• W2037602988 hasConcept C71924100 @default.
• W2037602988 hasConcept C86803240 @default.
• W2037602988 hasConcept C89423630 @default.
• W2037602988 hasConceptScore W2037602988C104317684 @default.
• W2037602988 hasConceptScore W2037602988C114851261 @default.
• W2037602988 hasConceptScore W2037602988C176947019 @default.
• W2037602988 hasConceptScore W2037602988C2777027569 @default.
• W2037602988 hasConceptScore W2037602988C2778910516 @default.
• W2037602988 hasConceptScore W2037602988C2780950330 @default.
• W2037602988 hasConceptScore W2037602988C42972112 @default.
• W2037602988 hasConceptScore W2037602988C4937899 @default.
• W2037602988 hasConceptScore W2037602988C501593827 @default.
• W2037602988 hasConceptScore W2037602988C547475151 @default.
• W2037602988 hasConceptScore W2037602988C55493867 @default.
• W2037602988 hasConceptScore W2037602988C71924100 @default.
• W2037602988 hasConceptScore W2037602988C86803240 @default.
• W2037602988 hasConceptScore W2037602988C89423630 @default.
• W2037602988 hasIssue "4" @default.
• W2037602988 hasLocation W20376029881 @default.
• W2037602988 hasLocation W20376029882 @default.
• W2037602988 hasLocation W20376029883 @default.
• W2037602988 hasLocation W20376029884 @default.
• W2037602988 hasOpenAccess W2037602988 @default.
• W2037602988 hasPrimaryLocation W20376029881 @default.
• W2037602988 hasRelatedWork W1964895857 @default.
• W2037602988 hasRelatedWork W2018303091 @default.
• W2037602988 hasRelatedWork W2040132723 @default.
• W2037602988 hasRelatedWork W2072511609 @default.
• W2037602988 hasRelatedWork W2126035312 @default.
• W2037602988 hasRelatedWork W2142109286 @default.
• W2037602988 hasRelatedWork W2334815962 @default.
• W2037602988 hasRelatedWork W2512784365 @default.

• next